Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cleft Palate | 6 | 2022 | 41 | 2.310 |
Why?
|
Fracture Fixation, Internal | 3 | 2019 | 38 | 1.040 |
Why?
|
Hand | 2 | 2023 | 65 | 0.920 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2014 | 46 | 0.870 |
Why?
|
Abdominoplasty | 1 | 2023 | 4 | 0.860 |
Why?
|
Skin Aging | 1 | 2023 | 11 | 0.850 |
Why?
|
Low Back Pain | 1 | 2023 | 120 | 0.770 |
Why?
|
Fracture Healing | 2 | 2019 | 25 | 0.730 |
Why?
|
Aeromonas | 1 | 2020 | 6 | 0.700 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2020 | 24 | 0.690 |
Why?
|
Bone Plates | 2 | 2019 | 28 | 0.670 |
Why?
|
Soft Tissue Infections | 1 | 2020 | 42 | 0.670 |
Why?
|
Radius Fractures | 1 | 2019 | 5 | 0.640 |
Why?
|
Wrist Injuries | 1 | 2019 | 11 | 0.640 |
Why?
|
Cleft Lip | 3 | 2014 | 24 | 0.640 |
Why?
|
Contracture | 1 | 2017 | 7 | 0.600 |
Why?
|
Apraxias | 1 | 2017 | 7 | 0.590 |
Why?
|
Ophthalmoplegia | 1 | 2017 | 4 | 0.590 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2017 | 10 | 0.590 |
Why?
|
Muscular Atrophy | 1 | 2017 | 26 | 0.580 |
Why?
|
Genetic Association Studies | 1 | 2017 | 120 | 0.560 |
Why?
|
Ulnar Artery | 2 | 2012 | 10 | 0.510 |
Why?
|
Alveolar Bone Grafting | 1 | 2014 | 2 | 0.490 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2014 | 43 | 0.470 |
Why?
|
Aneurysm | 2 | 2012 | 53 | 0.470 |
Why?
|
Health Care Costs | 1 | 2014 | 200 | 0.420 |
Why?
|
Basketball | 1 | 2012 | 2 | 0.400 |
Why?
|
Microsurgery | 6 | 1998 | 52 | 0.400 |
Why?
|
Vascular System Injuries | 1 | 2012 | 19 | 0.390 |
Why?
|
Frontal Sinus | 1 | 2011 | 4 | 0.380 |
Why?
|
Facial Bones | 1 | 2011 | 12 | 0.380 |
Why?
|
Skull Fractures | 1 | 2011 | 21 | 0.370 |
Why?
|
Hospitalization | 2 | 2014 | 1278 | 0.310 |
Why?
|
Bupivacaine | 2 | 2006 | 32 | 0.310 |
Why?
|
Esthetics | 2 | 2023 | 18 | 0.310 |
Why?
|
Surgical Flaps | 8 | 1998 | 102 | 0.310 |
Why?
|
Anesthetics, Local | 3 | 2006 | 63 | 0.310 |
Why?
|
Humans | 30 | 2023 | 59284 | 0.300 |
Why?
|
Thrombosis | 4 | 1996 | 195 | 0.300 |
Why?
|
Postoperative Complications | 8 | 1999 | 1127 | 0.290 |
Why?
|
Dexamethasone | 2 | 2006 | 191 | 0.290 |
Why?
|
Glucocorticoids | 2 | 2006 | 170 | 0.280 |
Why?
|
Ilium | 2 | 2005 | 5 | 0.260 |
Why?
|
Lentigo | 1 | 2005 | 1 | 0.250 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2005 | 2 | 0.250 |
Why?
|
Facial Neoplasms | 1 | 2005 | 7 | 0.250 |
Why?
|
Myxoma | 1 | 2005 | 14 | 0.250 |
Why?
|
Male | 18 | 2023 | 27480 | 0.240 |
Why?
|
Female | 15 | 2023 | 30798 | 0.220 |
Why?
|
Tendon Injuries | 1 | 2023 | 16 | 0.220 |
Why?
|
Thumb | 3 | 2023 | 26 | 0.210 |
Why?
|
Vascular Surgical Procedures | 3 | 2012 | 245 | 0.200 |
Why?
|
Hair | 1 | 2023 | 78 | 0.200 |
Why?
|
Adult | 16 | 2023 | 15729 | 0.200 |
Why?
|
Retrospective Studies | 8 | 2019 | 5967 | 0.200 |
Why?
|
Cesarean Section | 1 | 2023 | 96 | 0.190 |
Why?
|
Surgery, Plastic | 2 | 1993 | 13 | 0.190 |
Why?
|
Disability Evaluation | 1 | 2023 | 214 | 0.190 |
Why?
|
Developing Countries | 1 | 2022 | 84 | 0.190 |
Why?
|
Skin | 2 | 2023 | 350 | 0.180 |
Why?
|
Amputation, Traumatic | 3 | 1998 | 11 | 0.180 |
Why?
|
Leg Injuries | 2 | 1991 | 16 | 0.180 |
Why?
|
Self Report | 1 | 2023 | 366 | 0.180 |
Why?
|
Aeromonas veronii | 1 | 2020 | 1 | 0.180 |
Why?
|
Length of Stay | 2 | 2019 | 765 | 0.170 |
Why?
|
Upper Extremity | 1 | 2020 | 49 | 0.170 |
Why?
|
Microcirculation | 3 | 1996 | 50 | 0.170 |
Why?
|
Open Fracture Reduction | 1 | 2019 | 4 | 0.160 |
Why?
|
Hand Strength | 1 | 2019 | 27 | 0.160 |
Why?
|
Range of Motion, Articular | 1 | 2019 | 82 | 0.160 |
Why?
|
Injury Severity Score | 1 | 2019 | 103 | 0.160 |
Why?
|
Child, Preschool | 3 | 2017 | 1837 | 0.150 |
Why?
|
Fingers | 1 | 1998 | 42 | 0.150 |
Why?
|
Facies | 1 | 2017 | 7 | 0.150 |
Why?
|
Follow-Up Studies | 5 | 2019 | 2323 | 0.150 |
Why?
|
Geriatric Assessment | 1 | 2019 | 161 | 0.150 |
Why?
|
Chromosomes, Human, X | 1 | 2017 | 35 | 0.150 |
Why?
|
Pedigree | 1 | 2017 | 190 | 0.140 |
Why?
|
Snow | 1 | 1997 | 5 | 0.140 |
Why?
|
Pandemics | 1 | 2022 | 606 | 0.140 |
Why?
|
Genetic Testing | 1 | 2017 | 133 | 0.140 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1996 | 43 | 0.130 |
Why?
|
Pregnancy | 1 | 2023 | 2352 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2017 | 322 | 0.130 |
Why?
|
Accidental Falls | 1 | 1997 | 144 | 0.120 |
Why?
|
Surveys and Questionnaires | 1 | 2023 | 2584 | 0.120 |
Why?
|
Middle Aged | 8 | 2023 | 16232 | 0.120 |
Why?
|
Treatment Outcome | 4 | 2012 | 5141 | 0.120 |
Why?
|
Child | 6 | 2006 | 4298 | 0.120 |
Why?
|
Muscles | 1 | 1995 | 171 | 0.110 |
Why?
|
Phenotype | 1 | 2017 | 1155 | 0.110 |
Why?
|
Dextrans | 1 | 1993 | 44 | 0.110 |
Why?
|
Adolescent | 8 | 2011 | 5914 | 0.110 |
Why?
|
Ibuprofen | 1 | 1993 | 19 | 0.110 |
Why?
|
Graft Occlusion, Vascular | 1 | 1993 | 60 | 0.110 |
Why?
|
Carrier Proteins | 1 | 2017 | 709 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2017 | 759 | 0.100 |
Why?
|
Radial Artery | 1 | 1993 | 41 | 0.100 |
Why?
|
Cohort Studies | 1 | 2019 | 2435 | 0.100 |
Why?
|
Tendons | 1 | 1991 | 20 | 0.100 |
Why?
|
Radiography | 3 | 2011 | 505 | 0.090 |
Why?
|
Sampling Studies | 1 | 2011 | 66 | 0.090 |
Why?
|
Forehead | 1 | 2011 | 19 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 180 | 0.090 |
Why?
|
Faculty, Medical | 1 | 1993 | 202 | 0.090 |
Why?
|
Lactation Disorders | 1 | 1990 | 4 | 0.090 |
Why?
|
Microscopy, Electron, Scanning | 3 | 1996 | 103 | 0.090 |
Why?
|
Rabbits | 4 | 1996 | 330 | 0.090 |
Why?
|
Vascular Patency | 3 | 1996 | 133 | 0.090 |
Why?
|
Mutation | 1 | 2017 | 2425 | 0.080 |
Why?
|
Thrombophlebitis | 1 | 1989 | 16 | 0.080 |
Why?
|
Femoral Artery | 3 | 1996 | 91 | 0.080 |
Why?
|
Aged, 80 and over | 2 | 2019 | 5063 | 0.080 |
Why?
|
Breast | 1 | 1990 | 173 | 0.080 |
Why?
|
Infant | 2 | 2006 | 1527 | 0.080 |
Why?
|
Heparin | 1 | 1989 | 113 | 0.080 |
Why?
|
Leg | 3 | 1993 | 82 | 0.070 |
Why?
|
Intraoperative Care | 1 | 2006 | 36 | 0.070 |
Why?
|
Ondansetron | 1 | 2005 | 34 | 0.060 |
Why?
|
Aged | 5 | 2019 | 13285 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 2005 | 33 | 0.060 |
Why?
|
Tendon Transfer | 2 | 2023 | 5 | 0.060 |
Why?
|
Antiemetics | 1 | 2005 | 97 | 0.060 |
Why?
|
Heart Atria | 1 | 2005 | 137 | 0.060 |
Why?
|
Risk Assessment | 1 | 2011 | 1907 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 1991 | 2061 | 0.060 |
Why?
|
Tenosynovitis | 1 | 2023 | 6 | 0.050 |
Why?
|
Rupture, Spontaneous | 1 | 2023 | 22 | 0.050 |
Why?
|
United States | 1 | 2014 | 7492 | 0.050 |
Why?
|
Methods | 2 | 1999 | 39 | 0.050 |
Why?
|
Ultrasonography | 2 | 1993 | 449 | 0.050 |
Why?
|
Young Adult | 1 | 2011 | 4318 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 1993 | 170 | 0.050 |
Why?
|
Anastomosis, Surgical | 2 | 1993 | 97 | 0.050 |
Why?
|
Hand Injuries | 2 | 1992 | 11 | 0.050 |
Why?
|
Postoperative Care | 2 | 1999 | 112 | 0.040 |
Why?
|
Codeine | 1 | 1999 | 6 | 0.040 |
Why?
|
Cephalexin | 1 | 1999 | 4 | 0.040 |
Why?
|
Cephalosporins | 1 | 1999 | 16 | 0.040 |
Why?
|
Finger Injuries | 1 | 1999 | 12 | 0.040 |
Why?
|
Lidocaine | 1 | 1999 | 27 | 0.040 |
Why?
|
Epinephrine | 1 | 1999 | 45 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 1999 | 148 | 0.040 |
Why?
|
Analgesics, Non-Narcotic | 1 | 1999 | 35 | 0.040 |
Why?
|
Acetaminophen | 1 | 1999 | 52 | 0.040 |
Why?
|
Bone Transplantation | 2 | 1995 | 28 | 0.040 |
Why?
|
Tromethamine | 1 | 1996 | 2 | 0.030 |
Why?
|
Bleeding Time | 1 | 1996 | 6 | 0.030 |
Why?
|
Tolmetin | 1 | 1996 | 10 | 0.030 |
Why?
|
Ketorolac Tromethamine | 1 | 1996 | 5 | 0.030 |
Why?
|
Groin | 1 | 1996 | 14 | 0.030 |
Why?
|
New England | 1 | 1997 | 267 | 0.030 |
Why?
|
Platelet Aggregation | 1 | 1996 | 59 | 0.030 |
Why?
|
Analgesics, Opioid | 2 | 1999 | 493 | 0.030 |
Why?
|
Animals | 5 | 1996 | 19595 | 0.030 |
Why?
|
Alveolar Process | 1 | 1995 | 1 | 0.030 |
Why?
|
Thorax | 1 | 1995 | 34 | 0.030 |
Why?
|
Cadaver | 1 | 1995 | 102 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1996 | 249 | 0.030 |
Why?
|
Color | 1 | 1993 | 19 | 0.030 |
Why?
|
Mammaplasty | 1 | 1994 | 44 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1993 | 70 | 0.030 |
Why?
|
Anesthesia, Epidural | 1 | 1993 | 24 | 0.030 |
Why?
|
External Fixators | 1 | 1992 | 6 | 0.030 |
Why?
|
Graft Survival | 3 | 1995 | 279 | 0.030 |
Why?
|
Replantation | 1 | 1991 | 8 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 1991 | 20 | 0.020 |
Why?
|
Osteomyelitis | 1 | 1991 | 22 | 0.020 |
Why?
|
Blood Platelets | 1 | 1993 | 179 | 0.020 |
Why?
|
Debridement | 1 | 1991 | 26 | 0.020 |
Why?
|
Judgment | 1 | 1991 | 30 | 0.020 |
Why?
|
Foot | 1 | 1991 | 41 | 0.020 |
Why?
|
Bromocriptine | 1 | 1990 | 2 | 0.020 |
Why?
|
Biomechanical Phenomena | 1 | 1991 | 241 | 0.020 |
Why?
|
Angiography | 1 | 1990 | 145 | 0.020 |
Why?
|
Program Evaluation | 1 | 1993 | 483 | 0.020 |
Why?
|
Bone and Bones | 1 | 1991 | 155 | 0.020 |
Why?
|
Arteries | 1 | 1990 | 74 | 0.020 |
Why?
|
Dogs | 1 | 1991 | 316 | 0.020 |
Why?
|
Tibial Fractures | 1 | 1989 | 12 | 0.020 |
Why?
|
Multiple Trauma | 1 | 1989 | 26 | 0.020 |
Why?
|
Reoperation | 1 | 1989 | 249 | 0.020 |
Why?
|
Recurrence | 1 | 1989 | 576 | 0.020 |
Why?
|
Melanoma | 1 | 1987 | 334 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1983 | 11 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 1983 | 61 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1987 | 403 | 0.010 |
Why?
|
Mastectomy | 2 | 1994 | 52 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1987 | 1126 | 0.010 |
Why?
|
Titanium | 1 | 1999 | 58 | 0.010 |
Why?
|
Skull | 1 | 1995 | 57 | 0.010 |
Why?
|
Pulmonary Atelectasis | 1 | 1993 | 9 | 0.010 |
Why?
|
Urinary Catheterization | 1 | 1993 | 19 | 0.010 |
Why?
|
Anesthesia, General | 1 | 1993 | 45 | 0.010 |
Why?
|
Arthrodesis | 1 | 1992 | 8 | 0.010 |
Why?
|
Fractures, Bone | 1 | 1992 | 137 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1991 | 234 | 0.000 |
Why?
|
Prostheses and Implants | 1 | 1989 | 63 | 0.000 |
Why?
|
Chronic Disease | 1 | 1991 | 731 | 0.000 |
Why?
|
Smoking | 1 | 1993 | 830 | 0.000 |
Why?
|
Isoxsuprine | 1 | 1983 | 1 | 0.000 |
Why?
|
Prostaglandins F | 1 | 1983 | 1 | 0.000 |
Why?
|
Trimethaphan | 1 | 1983 | 1 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1983 | 8 | 0.000 |
Why?
|
Alprostadil | 1 | 1983 | 8 | 0.000 |
Why?
|
Bradykinin | 1 | 1983 | 8 | 0.000 |
Why?
|
Dinoprost | 1 | 1983 | 17 | 0.000 |
Why?
|